Tactile Systems Technology
Market Cap
US$858.1m
Last Updated
2019/10/15 00:31 UTC
Data Sources
Company Financials +
Executive Summary
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States.
Snowflake
Fundamentals
Flawless balance sheet with reasonable growth potential.
Share Price & News
How has Tactile Systems Technology's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
5.1%
TCMD
-0.003%
US Medical Equipment
1.3%
US Market
1 Year Return
-31.7%
TCMD
11.9%
US Medical Equipment
5.9%
US Market
Return vs Industry: TCMD underperformed the US Medical Equipment industry which returned 11.9% over the past year.
Return vs Market: TCMD underperformed the US Market which returned 5.9% over the past year.
Shareholder returns
| TCMD | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.1% | -0.003% | 1.3% |
| 30 Day | -14.2% | -3.0% | -1.9% |
| 90 Day | -16.4% | -0.6% | -1.8% |
| 1 Year | -31.7%-31.7% | 12.8%11.9% | 8.3%5.9% |
| 3 Year | 137.7%137.7% | 69.6%64.5% | 45.6%36.2% |
| 5 Year | n/a | 129.6%104.0% | 66.1%47.9% |
Price Volatility Vs. Market
How volatile is Tactile Systems Technology's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
A Look At The Intrinsic Value Of Tactile Systems Technology, Inc. (NASDAQ:TCMD)1 month ago | Simply Wall St
Is Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) 8.4% ROE Better Than Average?1 month ago | Simply Wall St
Have Tactile Systems Technology, Inc. (NASDAQ:TCMD) Insiders Been Selling Their Stock?Valuation
Is Tactile Systems Technology undervalued compared to its fair value and its price relative to the market?
100.8x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: TCMD ($45.24) is trading above our estimate of fair value ($38.66)
Significantly Undervalued: TCMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: TCMD is poor value based on its PE Ratio (100.8x) compared to the Medical Equipment industry average (40.1x).
PE vs Market: TCMD is poor value based on its PE Ratio (100.8x) compared to the US market (17.5x).
Price to Earnings Growth Ratio
Low PEG Ratio: TCMD is poor value based on its PEG Ratio (3.6x)
Price to Book Ratio
PB vs Industry: TCMD is overvalued based on its PB Ratio (8.7x) compared to the US Medical Equipment industry average (3.6x).
Next Steps
Future Growth
How is Tactile Systems Technology forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
27.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TCMD's forecast earnings growth (27.7% per year) is above the savings rate (2.7%).
Earnings vs Market: TCMD's earnings (27.7% per year) are forecast to grow faster than the US market (14.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TCMD's revenue (17% per year) is forecast to grow faster than the US market (7.3% per year).
High Growth Revenue: TCMD's revenue (17% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if TCMD's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Tactile Systems Technology performed over the past 5 years?
65.8%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: TCMD's earnings have grown significantly by 65.8% per year over the past 5 years.
Accelerating Growth: TCMD's earnings growth over the past year (37.2%) is below its 5-year average (65.8% per year).
Earnings vs Industry: TCMD earnings growth over the past year (37.2%) exceeded the Medical Equipment industry 28.2%.
Return on Equity
High ROE: TCMD's Return on Equity (8.4%) is considered low.
Return on Assets
ROA vs Industry: TCMD has a higher Return on Assets than the Medical Equipment industry average last year.
Return on Capital Employed
ROCE Improving: TCMD's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Tactile Systems Technology's financial position?
Financial Position Analysis
Short Term Liabilities: TCMD's short term assets ($94.1M) exceeds its short term liabilities ($18.7M)
Long Term Liabilities: TCMD's short term assets (94.1M) exceeds its long term liabilities (4.2M)
Debt to Equity History and Analysis
Debt Level: TCMD is debt free.
Reducing Debt: TCMD has no debt compared to 5 years ago when its debt to equity ratio was 0.07%.
Debt Coverage: TCMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TCMD has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: TCMD has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if TCMD's debt is covered by short term assets.
Next Steps
Dividend
What is Tactile Systems Technology's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate TCMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate TCMD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if TCMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TCMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TCMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Tactile Systems Technology's salary, the management and board of directors tenure and is there insider trading?
3.5yrs
Average management tenure
CEO
Jerry Mattys (59yo)
14.1yrs
Tenure
US$2,049,160
Compensation
Mr. Gerald R. Mattys, also known as Jerry, has been the Chief Executive Officer of Tactile Systems Technology, Inc. since 2005. Mr. Mattys served as the Chief Executive Officer of Medisyn Technologies Inc. ...
CEO Compensation Analysis
Compensation vs. Market: Jerry's total compensation ($USD2.05M) is about average for companies of similar size in the US market ($USD2.76M).
Compensation vs Earnings: Jerry's compensation has increased by more than 20% in the past year.
Management Age and Tenure
3.5yrs
Average Tenure
57.5yo
Average Age
Experienced Management: TCMD's management team is considered experienced (3.5 years average tenure).
Board Age and Tenure
5.4yrs
Average Tenure
60yo
Average Age
Experienced Board: TCMD's board of directors are considered experienced (5.4 years average tenure).
Insider Trading
Insider Buying: TCMD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 9,937 |
| Max Price | US$49.92 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 1,939 |
| Max Price | US$49.35 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 5,000 |
| Max Price | US$50.87 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 4,907 |
| Max Price | US$50.00 |
| Entity | Individual |
| Role | Chief Operating Officer Chief Operating Officer |
| Shares | 10,607 |
| Max Price | US$50.00 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 15,000 |
| Max Price | US$50.33 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 10,093 |
| Max Price | US$57.25 |
| Entity | Individual |
| Role | Chief Financial Officer Chief Financial Officer |
| Shares | 900 |
| Max Price | US$54.22 |
Ownership Breakdown
Management Team
Jerry Mattys (59yo)
CEO & Director
- Tenure: 14.1yrs
- Compensation: US$2.05m
Robert Folkes (56yo)
Chief Operating Officer
- Tenure: 4.7yrs
- Compensation: US$887.25k
Juleen Krings
Chief Human Resources Officer
- Tenure: 1.2yrs
Brent Moen (52yo)
Chief Financial Officer
- Tenure: 1.1yrs
- Compensation: US$1.16m
Thomas O’Donnell
Chief Medical Officer
- Tenure: 2.3yrs
Bryan Rishe (63yo)
Senior Vice President of Sales
- Tenure: 11.8yrs
- Compensation: US$989.37k
Sunday Hoy
VP & Compliance Officer
- Tenure: 0yrs
Darren Wennen
Vice President of Marketing & Clinical Affairs
- Tenure: 5.8yrs
Peter Schaubach
Chief Information Officer
- Tenure: 0.8yrs
Board Members
Dick Nigon (71yo)
Independent Director
- Tenure: 7.1yrs
- Compensation: US$184.44k
Ray Huggenberger (60yo)
Independent Director
- Tenure: 2.1yrs
- Compensation: US$173.20k
Bill Burke (60yo)
Independent Director
- Tenure: 4.1yrs
- Compensation: US$183.20k
Jerry Mattys (59yo)
CEO & Director
- Tenure: 14.1yrs
- Compensation: US$2.05m
Peter Soderberg (72yo)
Independent Chairman
- Tenure: 6.8yrs
- Compensation: US$207.05k
Cheryl Pegus (55yo)
Independent Director
- Tenure: 2.3yrs
- Compensation: US$179.20k
Kevin Roche (68yo)
Independent Director
- Tenure: 15yrs
- Compensation: US$179.20k
Anthony Comerota
Chairman of Scientific Advisory Board
- Tenure: 2.2yrs
Steven Dean
Member of Scientific Advisory Board
- Tenure: 6.8yrs
Christopher Pittman
Member of Scientific Advisory Board
- Tenure: 2.2yrs
Company Information
Tactile Systems Technology, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Tactile Systems Technology, Inc.
- Ticker: TCMD
- Exchange: NasdaqGM
- Founded: 1995
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$858.120m
- Shares outstanding: 18.97m
- Website: https://www.tactilemedical.com
Number of Employees
Location
- Tactile Systems Technology, Inc.
- 1331 Tyler Street NE
- Suite 200
- Minneapolis
- Minnesota
- 55413
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| TCMD | NasdaqGM (Nasdaq Global Market) | Yes | Common Stock | US | USD | Jul 2016 |
| 3L3 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jul 2016 |
Biography
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers Flexitouch system, an at ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/15 00:31 |
| End of Day Share Price | 2019/10/14 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.